Alteration of transforming growth factor beta1 (TGF-beta1) type II receptor (RII) appears to cause unresponsiveness to TGF-beta1 in tumorigenic cells. Defect in the mononucleotide repeat sequence, i.e., poly A region of TGF-beta1RII gene has been reported to be related to replication error-positive
Reduced transforming growth factor-β receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis
✍ Scribed by Mamiya, Takao; Yamazaki, Ken; Masugi, Yohei; Mori, Taisuke; Effendi, Kathryn; Du, Wenlin; Hibi, Taizo; Tanabe, Minoru; Ueda, Masakazu; Takayama, Tadatoshi
- Book ID
- 109885416
- Publisher
- Nature Publishing Group
- Year
- 2010
- Tongue
- English
- Weight
- 376 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0023-6837
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To elucidate the role of transforming growth factor-beta1 (TGF-beta1) and the TGF-beta type II receptor (TGF-beta RII) as tumor-suppressor genes in lung carcinogenesis, we mated C57BL/6 mice heterozygous (HT) for deletion of the TGF-beta1 gene with A/J mice to produce AJBL6 TGF-beta1 HT progeny and
## Abstract Transforming growth factor‐β (TGF‐β) inhibits epithelial cell proliferation. Inactivation of the TGF‐β signaling pathway is thought to play a role in tumorigenesis. Our purpose was to clarify the correlation between TGF‐β receptors or TGF‐β1 expression and the clinicopathologic characte
These studies investigate the role of transforming growth factor-61, a potent inhibitor of epithelial cell proliferation and stimulator of extracellular matrix biosynthesis, during intrahepatic bile duct hyperplasia and biliary fibrosis. These pathogenic responses were induced in rats by common bile